Breast Cancer News

Health Tips

• Health Tip: Breast Cancer Screening Guidelines
  
• Health Tip: Benign Breast Lumps
  
• Health Tip: Understanding Breast Biopsy
  

FDA Approvals

• FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer
  Approval indicated for those who have received at least two previous therapies
• Tukysa Approved for Unresectable, Metastatic HER2-Positive Breast Cancer
  Drug indicated for patients who have previously received treatment with one or more anti-HER2-based regimen
• Enhertu Approved for Unresectable, Metastatic HER2+ Breast Cancer
  Treatment indicated for patients who have received at least two previous anti-HER2-based regimens
• First PI3K Inhibitor Approved for Metastatic, Advanced Breast Cancer
  Piqray approved for HR-positive, HER2-negative, PIK3CA-mutated, metastatic or advanced breast cancer
• Ibrance Approval Expanded to Include Men With Breast Cancer
  
• Magnetic System Approved for Guiding Lymph Biopsies